Bart Koopman
University Medical Center Groningen(NL)University of Groningen(NL)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Synthesis and biological activity, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation(2020)57 cited
- → Intra-abdominal hypertension and abdominal compartment syndrome in patients admitted to the ICU(2020)55 cited
- → Association of homozygous variants of STING1 with outcome in human cervical cancer(2020)48 cited
- → Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations(2020)47 cited
- → Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non–Small-Cell Lung Cancer With Rare or Complex Mutational Profiles(2020)46 cited
- → Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature(2021)27 cited
- → Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort(2022)25 cited
- → A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses(2021)19 cited
- [Fatal tuberculosis during treatment with ruxolitinib].(2015)
- → Initial presentation of lymphangioleiomyomatosis in third trimester of pregnancy(2021)6 cited